Palatin Technologies Inc Sample Contracts

ARTICLE I
Stock Purchase Agreement • July 9th, 1998 • Palatin Technologies Inc • In vitro & in vivo diagnostic substances • New York
AutoNDA by SimpleDocs
OF
Palatin Technologies Inc • February 2nd, 2001 • In vitro & in vivo diagnostic substances • New York
COMMON STOCK PURCHASE WARRANT PALATIN TECHNOLOGIES, Inc.
Palatin Technologies Inc • February 1st, 2024 • Pharmaceutical preparations

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after August 1, 2024 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on February 1, 2028 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Palatin Technologies, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • February 1st, 2024 • Palatin Technologies Inc • Pharmaceutical preparations • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of January 29, 2024, between Palatin Technologies, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

RECITALS
Security Agreement • December 28th, 1999 • Palatin Technologies Inc • In vitro & in vivo diagnostic substances • New York
PALATIN TECHNOLOGIES, INC. REGISTRATION RIGHTS AGREEMENT Table of Contents
Registration Rights Agreement • December 10th, 2002 • Palatin Technologies Inc • Pharmaceutical preparations • New York
REGISTRATION RIGHTS AGREEMENT Table of Contents
Registration Rights Agreement • September 30th, 2002 • Palatin Technologies Inc • Pharmaceutical preparations • New York
COMMON STOCK PURCHASE WARRANT PALATIN TECHNOLOGIES, INC.
Palatin Technologies Inc • May 16th, 2022 • Pharmaceutical preparations

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the making of a Redemption Consideration Election (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on May 11, 2026 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Palatin Technologies, Inc., a Delaware corporation (the “Company”), up to [ ] shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

RECITALS
Purchase Agreement • September 29th, 2003 • Palatin Technologies Inc • Pharmaceutical preparations • New York
COMMON STOCK PURCHASE WARRANT PALATIN TECHNOLOGIES, INC.
Common Stock Purchase Warrant • June 28th, 2010 • Palatin Technologies Inc • Pharmaceutical preparations

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time or times on or after the date hereof (the “Exercisability Date”), but not after 11:59 p.m., New York City time, on June ___, 2011 (the “Termination Date”), to subscribe for and purchase from Palatin Technologies, Inc., a Delaware corporation (the “Company”), up to ______ shares (the “Warrant Shares”) of Common Stock.

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • October 24th, 2023 • Palatin Technologies Inc • Pharmaceutical preparations • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of October 20, 2023, between Palatin Technologies, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

BACKGROUND
Employment Agreement • November 30th, 1999 • Palatin Technologies Inc • In vitro & in vivo diagnostic substances • Delaware
SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • August 13th, 2009 • Palatin Technologies Inc • Pharmaceutical preparations • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of August 12, 2009, between Palatin Technologies, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

BACKGROUND
Registration Rights Agreement • September 29th, 2003 • Palatin Technologies Inc • Pharmaceutical preparations • New York
PALATIN TECHNOLOGIES, INC. PURCHASE AGREEMENT TABLE OF CONTENTS
Purchase Agreement • December 10th, 2002 • Palatin Technologies Inc • Pharmaceutical preparations • New York
AutoNDA by SimpleDocs
SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • March 1st, 2010 • Palatin Technologies Inc • Pharmaceutical preparations • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of February 24, 2010, between Palatin Technologies, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • May 16th, 2022 • Palatin Technologies Inc • Pharmaceutical preparations • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of May 11, 2022, between Palatin Technologies, Inc., a Delaware corporation (the “Company”), and the purchasers identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser”).

COMMON STOCK PURCHASE WARRANT PALATIN TECHNOLOGIES, INC.
Palatin Technologies Inc • May 16th, 2022 • Pharmaceutical preparations

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after May 11, 2022 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on May 11, 2026 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Palatin Technologies, Inc., a Delaware corporation (the “Company”), up to [833,333] shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

COMMON STOCK PURCHASE WARRANT PALATIN TECHNOLOGIES, INC.
Palatin Technologies Inc • June 28th, 2010 • Pharmaceutical preparations

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time or times on or after the date hereof (the “Exercisability Date”), but not after 11:59 p.m., New York City time, on November 26, 2012 (the “Termination Date”), to subscribe for and purchase from Palatin Technologies, Inc., a Delaware corporation (the “Company”), up to ______ shares (the “Warrant Shares”) of Common Stock. This Warrant is issued by the Company as of the date hereof pursuant to (i) Section 1 of the Engagement Agreement, dated June 25, 2010, by and between the Company and Rodman & Renshaw, LLC and (ii) Section 4(2) of the Securities Act and Rule 506 promulgated thereunder.

AMENDMENT TO STRATEGIC COLLABORATION AGREEMENT
Security Agreement • May 15th, 2002 • Palatin Technologies Inc • In vitro & in vivo diagnostic substances • New York
CONFIDENTIAL
Palatin Technologies Inc • June 28th, 2010 • Pharmaceutical preparations • New York
SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • June 28th, 2010 • Palatin Technologies Inc • Pharmaceutical preparations • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of June 25, 2010, between Palatin Technologies, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

Time is Money Join Law Insider Premium to draft better contracts faster.